Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyAmyloidosisTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyAmyloidosisTeam Member asked a question 💭
May 4
 · 
Be the first to react
MyAmyloidosisTeam

Currently, there is no guaranteed cure for systemic amyloidosis. However, that doesn't mean there's nothing to be hopeful about — treatments have come a long way and can slow the disease, protect organs, and help manage symptoms effectively. It's also worth understanding the difference between a "cure" and "remission":

- Show Full Answer

Currently, there is no guaranteed cure for systemic amyloidosis. However, that doesn't mean there's nothing to be hopeful about — treatments have come a long way and can slow the disease, protect organs, and help manage symptoms effectively. It's also worth understanding the difference between a "cure" and "remission":

- Cure means the underlying cause is completely gone, the disease won't return, and no further treatment is needed.
- Remission means symptoms have disappeared or are under control, but the disease may still return and ongoing monitoring is usually required.

For most people with systemic amyloidosis, remission is a realistic and meaningful goal. There are also some exciting treatments being researched that could change the picture in the future, including:

- CRISPR gene-editing technology — A clinical trial is underway testing a drug (NTLA-2001) that targets the root cause of hereditary ATTR amyloidosis by deleting the TTR gene in the liver. This could potentially be a cure.
- PRX-004 — An antibody that may lower amyloid protein levels.
- Doxycycline — An antibiotic being studied for its ability to break apart amyloid fibrils.

These are still in research stages, so talking to a specialist about clinical trial eligibility could be worth exploring. The outlook for systemic amyloidosis really does depend on the type, how early it was caught, and which organs are affected. Early diagnosis tends to lead to better outcomes, and with newer therapies continuing to emerge, there is genuine reason for hope.

May 4

Related Questions

View All
A MyAmyloidosisTeam Member asked a question 💭

A MyAmyloidosisTeam Member asked a question 💭
Toorak Victoria Australia

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In